Southpoint Capital Advisors LP 13D/13G Filings for Fennec Pharmaceuticals Inc. (FENC)

Southpoint Capital Advisors LP 13D and 13G filings for Fennec Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-12
4:00 pm
Purchase
2020-12-3113GFennec Pharmaceuticals Inc.
FENC
Southpoint Capital Advisors LP4,077,214
15.800%
80,000increase
(+2.00%)
Filing